Company Filing History:
2 out of 158 
1 out of 4,449 
1 out of 33 
Years Active: 1999-2024
Title: Gregory A Dekaban: Innovator in Central Nervous System Treatments
Introduction
Gregory A Dekaban is a notable inventor based in London, Canada. He has made significant contributions to the field of medical science, particularly in the treatment of central nervous system injuries. With a total of 4 patents to his name, Dekaban's work focuses on innovative solutions for complex medical challenges.
Latest Patents
Among his latest patents is the development of Anti-CD11D antibodies and their uses. This invention includes antibodies to human CD11d, compositions comprising such CD11d antibodies, and methods for using these antibodies to treat central nervous system trauma. This includes spinal cord injuries and traumatic brain injuries, as well as addressing systemic inflammatory responses following such trauma. Another significant patent is related to metabolomics profiling of central nervous system injury. This method provides a way to diagnose various central nervous system injuries, including acquired brain injury and acquired spinal cord injury. The process involves obtaining a biological test sample, identifying metabolites, and using statistical analysis and machine learning to compare profiles to determine the presence of CNS injuries.
Career Highlights
Gregory A Dekaban has worked with esteemed institutions, including the University of Western Ontario. His research and innovations have contributed to advancements in medical treatments and diagnostics.
Collaborations
Some of his notable coworkers include Arthur Brown and Jacqueline Arp. Their collaborative efforts have furthered the impact of Dekaban's inventions in the medical field.
Conclusion
Gregory A Dekaban's work exemplifies the spirit of innovation in medical science. His patents and research are paving the way for new treatments and diagnostic methods for central nervous system injuries.